|
See related Fosrenol chewable tab information |
|
|
|
Manufacturer |
Shire |
|
Distributor |
Hong Kong: Hind Wing |
|
Contents |
Lanthanum carbonate |
|
Indications |
Control of hyperphosphataemia in chronic renal failure patients on haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). |
|
Dosage |
Adult & elderly (>65 yr) Control of serum phosphate level Initially 750 mg/day. Max: 3,750 mg. Maintenance: 1,500-3,000 mg/day. |
|
Administration |
Should be taken with food (Take w/ or immediately after meals. Chew thoroughly before swallowing. Do not swallow whole.). |
|
Contraindications |
Hypophosphataemia. |
|
Special Precautions |
Acute peptic ulcer, ulcerative colitis, Crohn's disease or bowel obstruction. Monitor serum Ca levels in patients w/ renal insufficiency. Severe hepatic impairment. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn. |
|
Adverse Drug Reactions |
GI reactions eg abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, nausea & vomiting. Hypocalcaemia.
View ADR Monitoring Form |
|
Drug Interactions |
Chloroquine, hydroxychloroquine & ketoconazole. Tetracycline, doxycycline & floxacins.
View more drug interactions with Fosrenol |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
ATC Classification |
V03AE03 - lanthanum carbonate ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Fosrenol chewable tablet |
|
|
|
Manufacturer: |
Shire |
|
Distributor: |
Hong Kong: Hind Wing
|
|
|
|
